Tolera Therapeutics
Kalamazoo, US
Founders & leadership
AP
Ashleigh PalmerExecutive
Board
MO
Mark OlesnavageBoard director
SD
Suzette DutchBoard director
DP
Donald ParfetBoard director
DM
Douglas MortonBoard director
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2014
▶$250KraisedSep 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$250KraisedSep 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas MortonDirector
- Mark OlesnavageDirector
- Suzette DutchDirector
- Donald ParfetDirector
- Ashleigh PalmerExecutive Officer
- Amount sold
- $250K
- Minimum investment
- $1K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Tolera Therapeutics raised?
- Tolera Therapeutics has disclosed $250K raised across 1 round.
- Where is Tolera Therapeutics headquartered?
- Tolera Therapeutics is headquartered in Kalamazoo, US.